• Abbisko Cayman will hold an extraordinary general meeting in Shanghai on Sept. 17, 2026.
• Shareholders will vote on a proposal to change the company name to Abbisko Medicine Co., Ltd.
• The Chinese dual foreign name is also set to change to 和譽醫藥有限責任公司.
• Stock short names ABBISKO-B and 和譽-B, plus stock code 2256, are set to remain unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12304087), on August 28, 2026, and is solely responsible for the information contained therein.